MindBio Therapeutics Corp.
MBIO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -415.60K |
| Total Revenue | -- | -- | -- | -- | -415.60K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -415.60K |
| SG&A Expenses | 4.76M | 3.44M | 1.94M | 1.20M | 265.30K |
| Depreciation & Amortization | -56.60K | -56.60K | 1.20K | 1.00K | -600.00 |
| Other Operating Expenses | 17.10K | 17.10K | 17.10K | 17.80K | 17.80K |
| Total Operating Expenses | 4.72M | 3.40M | 1.96M | 1.22M | 282.50K |
| Operating Income | -4.72M | -3.40M | -1.96M | -1.22M | -698.10K |
| Income Before Tax | -4.71M | -3.89M | -2.55M | -1.79M | -1.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.71 | -3.89 | -2.55 | -1.79 | -1.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.20K | -3.30K | 0.00 | -100.00 | 3.20K |
| Net Income | -4.71M | -3.89M | -2.55M | -1.79M | -1.04M |
| EBIT | -4.72M | -3.40M | -1.96M | -1.22M | -698.10K |
| EBITDA | -1.76M | -1.83M | -1.93M | -1.14M | -168.40K |
| EPS Basic | -3.06 | -4.64 | -4.34 | -3.53 | -3.52 |
| Normalized Basic EPS | -2.10 | -2.17 | -1.99 | -1.48 | -1.28 |
| EPS Diluted | -3.06 | -4.64 | -4.34 | -3.53 | -3.52 |
| Normalized Diluted EPS | -1.67 | -1.75 | -1.99 | -1.48 | -1.28 |
| Average Basic Shares Outstanding | 11.41M | 3.71M | 2.55M | 1.97M | 1.13M |
| Average Diluted Shares Outstanding | 13.97M | 6.27M | 2.55M | 1.97M | 1.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |